NCT06413459View on ClinicalTrials.gov

Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic Fibrosis

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

April 8, 2021

Primary Completion Date

March 30, 2027

Study Completion Date

March 30, 2027

Conditions

Non-Tuberculous Mycobacterial PneumoniaCystic Fibrosis Lung

Interventions

OTHER

Luminex; scRNAsec

Evaluation of specific cell populations associated with development of M. abscessus lung disease; evaluation of circulating factors related to immunoresponses

Trial Locations (1)

20132

RECRUITING

Ospedale San Raffaele, Milan

All Listed Sponsors

collaborator

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

OTHER

lead

Ospedale San Raffaele

OTHER